APPlife Digital Solutions (ALDS) 10-Q 15 May 24 2024 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2024	May 13, 2024
Details
Registrant CIK	0001755101
Fiscal Year End	--06-30
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Securities Act File Number	000-54524
Entity Registrant Name	APPLIFE DIGITAL SOLUTIONS, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	30-0678378
Entity Address, Address Line One	50 California St
Entity Address, Address Line Two	#1500
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
City Area Code	415
Local Phone Number	439 5260
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		150,543,635
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current assets
Cash	$ 28,740	$ 57,619
Accounts receivable	1,680	0
Prepaid expenses	33,430	35,436
Inventories	45,373	65,209
Total current assets	109,223	158,264
Deposit on asset purchase	100,000	0
Total assets	209,223	158,264
Current liabilities
Accounts payable and accrued expenses	326,351	157,696
Notes payable	0	16,051
Convertible notes payable to stockholder	356,160	262,955
Notes payable to stockholder	380,000	0
Derivative liabilities	824,775	1,004,846
Due to officer	51,000	1,000
Total current liabilities	1,938,286	1,442,548
Convertible notes payable to stockholder - noncurrent, net	124,510	151,777
Total liabilities	2,062,796	1,594,325
Stockholders' deficit
Common stock, $0.001 par value, 500,000,000 shares authorized; 150,543,635 shares issued and outstanding as of both March 31, 2024 and June 30, 2023	150,545	150,545
Additional paid-in capital	16,659,877	15,287,798
Accumulated deficit	(18,663,995)	(16,874,404)
Total stockholders' deficit	(1,853,573)	(1,436,061)
Total liabilities and stockholders' deficit	$ 209,223	$ 158,264

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - Parenthetical - $ / shares	Mar. 31, 2024	Jun. 30, 2023
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	150,543,635	150,543,635
Common Stock, Shares, Outstanding	150,543,635	150,543,635

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 2,348	$ 12,355	$ 8,146	$ 43,374
Cost of goods sold	(7,708)	(9,635)	(20,020)	(35,531)
Gross (loss) profit	(5,360)	2,700	(11,874)	7,843
Operating expenses	553,274	778,425	1,724,564	2,252,802
Total operating expenses	553,274	778,425	1,724,564	2,252,802
Loss from operations	(558,634)	(775,725)	(1,736,438)	(2,244,959)
Other income (expense)
Interest expense	(159,650)	(148,812)	(521,522)	(479,187)
Gain on termination of conversion feature on debt	0	0	417,526	0
Change in fair value of derivative liability	79,790	91,241	50,843	341,913
Net loss before provision for income taxes	(638,494)	(833,296)	(1,789,591)	(2,382,233)
Provision for income taxes	0	0	0	0
Net loss	$ (638,494)	$ (833,296)	$ (1,789,591)	$ (2,382,233)
Basic and diluted loss per share	$ (0.01)	$ (0.02)	$ (0.03)	$ (0.04)
Average number of common shares outstanding - basic and diluted	60,543,635	53,076,511	60,543,635	53,076,511

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Equity, Attributable to Parent, Beginning Balance at Jun. 30, 2022	$ 148,545	$ 12,410,428	$ (13,377,831)	$ (818,858)
Shares, Outstanding, Beginning Balance at Jun. 30, 2022	148,543,635
Stock compensation expense	$ 0	(1,664,046)	0	(1,664,046)
Common stock issued for services, Value	$ 1,500	16,800	0	18,300
Common stock issued for services, Shares	1,500,000
Net loss	$ 0	0	(2,382,233)	(2,382,233)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2023	$ 150,045	14,527,318	(15,760,064)	(1,082,701)
Shares, Outstanding, Ending Balance at Mar. 31, 2023	150,043,635
Stock compensation expense	$ 0	1,664,046	0	1,664,046
Settlement of notes payable with issuance of options to purchase common stock	0	436,044	0	0
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2022	$ 148,545	12,905,804	(14,037,578)	(983,229)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	148,543,635
Stock compensation expense	$ 0	(586,937)	0	(586,937)
Common stock issued for services, Value	$ 1,500	16,800	0	18,300
Common stock issued for services, Shares	1,500,000
Net loss	$ 0	0	(833,296)	(833,296)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2023	$ 150,045	14,527,318	(15,760,064)	(1,082,701)
Shares, Outstanding, Ending Balance at Mar. 31, 2023	150,043,635
Stock compensation expense	$ 0	586,937	0	586,937
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	0
Equity, Attributable to Parent, Beginning Balance at Jun. 30, 2023	$ 150,545	15,287,798	(16,874,404)	(1,436,061)
Shares, Outstanding, Beginning Balance at Jun. 30, 2023	150,543,635
Stock compensation expense	$ 0	(1,372,079)	0	(1,372,079)
Common stock issued for services, Value				0
Net loss	0	0	(1,789,591)	(1,789,591)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2024	$ 150,545	16,659,877	(18,663,995)	(1,853,573)
Shares, Outstanding, Ending Balance at Mar. 31, 2024	150,543,635
Stock compensation expense	$ 0	1,372,079	0	1,372,079
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023	$ 150,545	16,197,818	(18,025,501)	(1,677,138)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023	150,543,635
Stock compensation expense	$ 0	(462,059)	0	(462,059)
Net loss	0	0	(638,494)	(638,494)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2024	$ 150,545	16,659,877	(18,663,995)	(1,853,573)
Shares, Outstanding, Ending Balance at Mar. 31, 2024	150,543,635
Stock compensation expense	$ 0	$ 462,059	$ 0	$ 462,059

UNAUDITED STATEMENTS OF CASH FL

UNAUDITED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,789,591)	$ (2,382,233)
Adjustment to reconcile change in net loss to net cash used in operating activities
Amortization	415,938	315,811
Interest expense	44,053	35,336
Common stock issued for services, Value	0	18,300
Stock compensation expense	1,372,079	1,664,046
Gain on termination of conversion feature on debt	(417,526)
Change in fair value of derivative liability	(50,843)	(341,913)
Changes in operating assets and liabilities
Accounts receivable	(1,680)	0
Prepaid expenses and other current assets	(14,045)	(4,782)
Inventories	19,836	(15,841)
Accounts payable and accrued expenses	132,900	133,287
Net Cash Provided by (Used in) Operating Activities	(288,879)	(577,989)
CASH FLOWS FROM INVESTING ACTIVITIES
Deposits paid for the purchase of assets from Le Salon	(100,000)	0
Net cash used in investing activities	(100,000)	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable to stockholders	310,000	445,000
Proceeds from amounts due to officer	50,000	1,000
Net cash provided from financing activities	360,000	446,000
Net decrease in cash and cash equivalents	(28,879)	(131,989)
Cash and cash equivalents, beginning of period	57,619	189,233
Cash and cash equivalents, end of period	28,740	57,244
Non-cash investing and financing activities
Increase in derivative liability upon issuance of convertible note	280,000	379,700
Payment of notes payable with issuance of options to purchase common stock	$ 0	$ 436,044

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2024
Notes
Note 1 - Organization and Summary of Significant Accounting Policies	Note 1 – Organization, Going Concern and Summary of Significant Accounting Policies Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. Our office in San Francisco, California allows us to take advantage of the marketing opportunities available in the United States as well as keeping close proximity to sources of capital whether it is debt or equity. Our offices in Shanghai, China allows us to take advantage of a high concentration of skilled tech coders and developers at lower capital costs than in more developed countries such as the United States or Europe. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms. Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern. Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2023, as filed with the SEC on October 2, 2023. Operating results for the three months and nine months ended March 31, 2024 are not necessarily indicative of the results that may be expected for any subsequent quarter or for the fiscal year ending June 30, 2024. Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less. Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2024. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California. Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, “Revenue from Contracts with Customers”, Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. As of March 31, 2024 and June 30, 2023, there were 74,393,933 and 30,499,099 potentially dilutive securities, respectively. As of March 31, 2024 and 2023, there were 90,000,000 restricted stock units to Matt Reid, respectively, that were excluded in the calculation of the weighted-average number of common shares outstanding during the period since they are still unvested. Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s condensed consolidated financial statements for cash, accounts receivable, accounts payable, notes payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments. Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2024, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument. Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2024, the Company had inventories of approximately $45,373, net of allowance for inventory reserves amounting to $2,736.

Note 2 - Notes payable

Note 2 - Notes payable	9 Months Ended
	Mar. 31, 2024
Notes
Note 2 - Notes payable	Note 2 – Notes payable On January 5, 2023, the Company financed its insurance premiums through its insurance broker amounting to $40,127 that carries an annual interest rate of 12% and matures through November 2023 in ten equal payments of $4,013. The net carrying amount of the note is $0 and $16,051 as of March 31, 2024 and June 30, 2023, respectively.

Note 3 - Convertible notes paya

Note 3 - Convertible notes payable to stockholder	9 Months Ended
	Mar. 31, 2024
Notes
Note 3 - Convertible notes payable to stockholder	Note 3 – Convertible notes payable to stockholder On February 4, 2022, the Company sold convertible note bearing 12% interest per annum in the principal amount of $350,000 (“February 2022 Notes”). The note will be paid in three tranches with first tranche of $100,000 received on March 28, 2022. The second and third tranches of $150,000 and $100,000 each, were received on May 3, 2022, and June 21, 2022, respectively. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $ 0.013. The February 2022 Notes contain embedded derivatives, see Note 8. On August 26, 2022, the Company sold convertible note bearing 12% interest per annum in the principal amount of $325,000 (“August 2022 Notes”). The note is disbursed in three tranches with first tranche of $125,000 received on September 1, 2022. The second tranche of $100,000 was received on September 19, 2022 and the third tranche of $100,000 was received on October 15, 2022. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.046. The August 2022 Notes contain embedded derivatives, see Note 8. On December 21, 2022, the Company sold convertible note bearing 12% interest per annum in the principal amount of $120,000 (“December 2022 Notes”). The note is disbursed in four tranches with first tranche of $40,000 received on January 10, 2023, and the remaining tranches of $20,000, $20,000 and $40,000 received on February 10, 2023, March 3, 2023 and March 31, 2023, respectively. The December 2022 Notes contain embedded derivatives, see Note 8. On April 24, 2023, the Company sold convertible note bearing 12% interest per annum in the principal amount of $280,000 (“April 24, 2023 Notes”). The first tranche of $80,000 was received on July 31, 2023 and the remaining tranches of $100,000 each received on October 13, 2023 and December 1, 2023, respectively. The April 24, 2023 Notes contain embedded derivatives, see Note 8. On April 30, 2023, the Company sold convertible note bearing 12% interest per annum in the principal amount of $100,000 (“April 30, 2023 Notes”). The note is disbursed in three tranches with the first tranche of $20,000 received on May 12, 2023, and the remaining tranches of $40,000 each received on May 31, 2023 and June 28, 2023, respectively. The April 30, 2023 Notes contain embedded derivatives, see Note 8. On September 27, 2023, the Company converted the first tranche of the February 2022 Notes with principal balance amounting to $100,000 and $18,016 of accrued interest into 5,632,283 stock options. The options expire in five years with the exercise price at $0.02. The options were valued at $167,961 using Black Scholes. On December 31, 2023, the Company amended the terms of the February 2022 Notes by revising its settlement from conversion into shares of the Company’s common stock to cash upon maturity, which is twelve (12) months following the date of amendment, losing the convertible feature of the February 2022 Notes and retaining the principal and interest on the 1 st On January 30, 2024, the company issued a promissory note bearing 12% interest per annum in the principal amount of $30,000. The note has a maturity date of January 25, 2025. The net carrying amount of the notes payable to stockholder is $380,000 and $0 as of March 31, 2024 and June 30, 2023, respectively. The remainder are convertible notes payable totaling $825,000. The outstanding balance of notes payable were as follows: March 31, 2024 June 30, 2023 Principal balance $ 1,205,000 $ 895,000 Unamortized debt discount (344,330) (480,268) $ 860,670 $ 414,732 A detailed roll forward schedule is shown as follows: Amount Balance of convertible notes payable, net of discount on June 30, 2023 $ 414,732 Amortization of debt discount 415,938 New Issuances 310,000 Embedded Conversion Feature - Debt discount (280,000) Notes Payable without conversion feature (380,000) Balance of convertible notes payable, net of discount as of March 31, 2024 $ 480,670 Less current portion of convertible notes payable, net of discount as of March 31, 2024 356,160 Noncurrent portion of convertible notes payable, net of discount as of March 31, 2024 $ 124,510

Note 4 - Concentrations

Note 4 - Concentrations	9 Months Ended
	Mar. 31, 2024
Notes
Note 4 - Concentrations	Note 4 – Concentrations Cash Concentration The Company maintains its cash and cash equivalents at financial institutions in the United States and China, which may, at times, exceed federally insured limits or similar limits in foreign jurisdictions. On March 31, 2024, the Company’s cash balance did not exceed the FDIC insurance limit. The Company has not experienced any losses in such accounts.

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	9 Months Ended
	Mar. 31, 2024
Notes
Note 5 - Commitments and Contingencies	Note 5 – Commitments and Contingencies Legal Matters From time to time the Company may be involved in certain legal actions and claims arising in the ordinary course of business. The Company was not a party to any specific legal actions or claims at March 31, 2024. Other Risks There have been outbreaks in several countries, including the United States, of the highly transmissible and pathogenic coronavirus (“COVID-19”). The outbreak of such COVID-19 resulted in a widespread health crisis that adversely affected general commercial activity and the economies and financial markets of many countries, including the United States. Although to date, the Company has not been adversely affected by COVID-19, the measures taken by the governments of countries affected could adversely affect the Company’s business, financial condition, and results of operations. Le Salon Asset Purchase On January 11, 2024, the Company agreed to pay Le Salon, a third party, a total consideration of $1,400,000 for the acquisition of certain intellectual property rights. The consideration comprised $100,000 in cash and $1,300,000 in the Company’s common stock. The intellectual property (“IP”) is currently being transitioned, and the Company expects the IP will be operational around the first quarter of 2025. Until the transfer of control is completed, the Company will not recognize the acquired IP on its balance sheet. As of March 31, 2024, the Company did not issue the stock for the purchase of the IP.

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit	9 Months Ended
	Mar. 31, 2024
Notes
Note 6 - Stockholders' Deficit	Note 6 – Stockholders’ Deficit As of March 31, 2024, and June 30, 2023, there were 150,543,635 shares of common stock issued and outstanding. Restricted stock and stock options During the three and nine months ended March 31, 2024, the Company recognized stock compensation expense on outstanding restricted stock awards and stock options of $462,059 and $1,372,079, respectively. During the three and nine months ended March 31, 2023, the Company recognized stock compensation expense on outstanding restricted stock awards and stock options of $586,937 and $1,664,046, respectively. During the three and nine months ended March 31, 2024, the Company recognized $106,560 and $297,860 of expense related to the vesting of stock options to its board members and consultants. During the three and nine months ended March 31, 2023, the Company recognized $28,233 and $232,324 of expense related to the vesting of stock options to its board members and consultants. Stock compensation expense is summarized as follows: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended March 31, 2024 March 31, 2023 March 31, 2024 March 31, 2023 Restricted stock awards $ 355,469 $ 558,714 $ 1,074,219 $ 1,431,722 Stock options awards 106,560 28,233 297,860 232,324 Total $ 462,059 $ 586,937 $ 1,372,079 $ 1,664,046 During the nine months ended March 31, 2024, the Company granted 28,710,133 options to its board members and consultants and cancelled 5,638,283 options to one of its stockholders. The options granted in fiscal year 2024 vest pro-rata over the member’s term, have exercise prices ranging from $0.01 - $0.036 and expire in five years from the date of grant. Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2023 51,322,083 $ 0.04 4.14 Granted 28,710,133 0.03 6.57 Reversal of conversion (5,638,283) - - Exercised - - - Outstanding – March 31, 2024 74,393,933 $ 0.04 3.74 Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92 Granted 6,997,064 0.03 4.69 Exercised - - - Outstanding – March 31, 2023 30,499,099 $ 0.05 4.25 In connection with the options the Company and valued with Black Scholes using the following inputs: Nine Months Ended March 31, 2024 Nine Months Ended March 31, 2023 Stock price $ 0.01 – 0.04 $ 0.02 – 0.03 Exercise price $ 0.01 – 0.04 $ 0.02 – 0.34 Expected term (in years) 1.00 - 5.00 4.94 – 5.00 Volatility (annual) 195.6% - 297.8 % 196.5% – 380.5 % Risk-free rate 3.48% - 4.25 % 2.42% - 4.22 %

Note 7 - Derivative Liability

Note 7 - Derivative Liability	9 Months Ended
	Mar. 31, 2024
Notes
Note 7 - Derivative Liability	Note 7 – Derivative Liability The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion option and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period. A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the Nine Months Ended March 31, 2024 is as follows: Nine Months Ended March 31, 2024 Stock price $ 0.01 – 0.04 Exercise price $ 0.01 – 0.03 Contractual term (in years) 0.42 – 1.50 Volatility (annual) 237% - 302% Risk-free rate 4.23% – 5.04% The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations. Financial Liabilities Measured at Fair Value on a Recurring Basis Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at March 31, 2024 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2024 Derivative liability $ - $ - $ 824,775 $ 824,775 Total $ - $ - $ 824,775 $ 824,775 Fair value measured at June 30, 2023 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2023 Derivative liability $ - $ - $ 1,004,846 $ 1,004,846 Total $ - $ - $ 1,004,846 $ 1,004,846 The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows: · Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets; · Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and · Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions. There were no transfers between Level 1, 2 or 3 during the nine months ended March 31, 2024. During the three and nine months ended March 31, 2024, the Company recorded losses of $79,790 and $50,843 respectively, from the change in fair value of derivative liability. During the three and nine months ended March 31, 2023, the Company recorded gains of $91,241 and $341,913 respectively, from the change in fair value of derivative liability. The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2024: Derivative Liability Balance as of June 30, 2023 $ 1,004,846 Additions during the period 288,298 Change due to conversion to stock options (86,199) Reversal of converted options 86,199 Change in fair value (50,843) Change due to termination of conversion feature on debt (417,526) Balance as of March 31, 2024 $ 824,775 The balance of the derivative liability at March 31, 2024 and June 30, 2023 was $824,775 and $1,004,846, respectively.

Note 8 - Subsequent Events

Note 8 - Subsequent Events	9 Months Ended
	Mar. 31, 2024
Notes
Note 8 - Subsequent Events	Note 8 – Subsequent Events The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q and determined that no material events occurred.

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies: Organization (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Organization	Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. Our office in San Francisco, California allows us to take advantage of the marketing opportunities available in the United States as well as keeping close proximity to sources of capital whether it is debt or equity. Our offices in Shanghai, China allows us to take advantage of a high concentration of skilled tech coders and developers at lower capital costs than in more developed countries such as the United States or Europe. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms.

Note 1 - Organization and Sum_3

Note 1 - Organization and Summary of Significant Accounting Policies: Going Concern (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Going Concern	Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern.

Note 1 - Organization and Sum_4

Note 1 - Organization and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2023, as filed with the SEC on October 2, 2023. Operating results for the three months and nine months ended March 31, 2024 are not necessarily indicative of the results that may be expected for any subsequent quarter or for the fiscal year ending June 30, 2024.

Note 1 - Organization and Sum_5

Note 1 - Organization and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less.

Note 1 - Organization and Sum_6

Note 1 - Organization and Summary of Significant Accounting Policies: Income Taxes (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Income Taxes	Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2024. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California.

Note 1 - Organization and Sum_7

Note 1 - Organization and Summary of Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Use of Estimates	Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates.

Note 1 - Organization and Sum_8

Note 1 - Organization and Summary of Significant Accounting Policies: Revenue Recognition (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Revenue Recognition	Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, “Revenue from Contracts with Customers”,

Note 1 - Organization and Sum_9

Note 1 - Organization and Summary of Significant Accounting Policies: Stock Based Compensation (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Stock Based Compensation	Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Note 1 - Organization and Su_10

Note 1 - Organization and Summary of Significant Accounting Policies: Net Loss per Share (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Net Loss per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. As of March 31, 2024 and June 30, 2023, there were 74,393,933 and 30,499,099 potentially dilutive securities, respectively. As of March 31, 2024 and 2023, there were 90,000,000 restricted stock units to Matt Reid, respectively, that were excluded in the calculation of the weighted-average number of common shares outstanding during the period since they are still unvested.

Note 1 - Organization and Su_11

Note 1 - Organization and Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s condensed consolidated financial statements for cash, accounts receivable, accounts payable, notes payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments.

Note 1 - Organization and Su_12

Note 1 - Organization and Summary of Significant Accounting Policies: Derivative Liability (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Derivative Liability	Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2024, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument.

Note 1 - Organization and Su_13

Note 1 - Organization and Summary of Significant Accounting Policies: Inventories (Policies)	9 Months Ended
	Mar. 31, 2024
Policies
Inventories	Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2024, the Company had inventories of approximately $45,373, net of allowance for inventory reserves amounting to $2,736.

Note 3 - Convertible notes pa_2

Note 3 - Convertible notes payable to stockholder: Disclosure of Notes payable to stockholders (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Disclosure of Notes payable to stockholders	March 31, 2024 June 30, 2023 Principal balance $ 1,205,000 $ 895,000 Unamortized debt discount (344,330) (480,268) $ 860,670 $ 414,732

Note 3 - Convertible notes pa_3

Note 3 - Convertible notes payable to stockholder: Schedule of Debt (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Schedule of Debt	Amount Balance of convertible notes payable, net of discount on June 30, 2023 $ 414,732 Amortization of debt discount 415,938 New Issuances 310,000 Embedded Conversion Feature - Debt discount (280,000) Notes Payable without conversion feature (380,000) Balance of convertible notes payable, net of discount as of March 31, 2024 $ 480,670 Less current portion of convertible notes payable, net of discount as of March 31, 2024 356,160 Noncurrent portion of convertible notes payable, net of discount as of March 31, 2024 $ 124,510

Note 6 - Stockholders' Deficit_

Note 6 - Stockholders' Deficit: Schedule of Stock Compensation Expense (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Schedule of Stock Compensation Expense	Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended March 31, 2024 March 31, 2023 March 31, 2024 March 31, 2023 Restricted stock awards $ 355,469 $ 558,714 $ 1,074,219 $ 1,431,722 Stock options awards 106,560 28,233 297,860 232,324 Total $ 462,059 $ 586,937 $ 1,372,079 $ 1,664,046

Note 6 - Stockholders' Defici_2

Note 6 - Stockholders' Deficit: Schedule of Stock Option Activity (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Schedule of Stock Option Activity	Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2023 51,322,083 $ 0.04 4.14 Granted 28,710,133 0.03 6.57 Reversal of conversion (5,638,283) - - Exercised - - - Outstanding – March 31, 2024 74,393,933 $ 0.04 3.74 Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92 Granted 6,997,064 0.03 4.69 Exercised - - - Outstanding – March 31, 2023 30,499,099 $ 0.05 4.25

Note 6 - Stockholders' Defici_3

Note 6 - Stockholders' Deficit: Schedule of Assumptions Used (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Schedule of Assumptions Used	Nine Months Ended March 31, 2024 Nine Months Ended March 31, 2023 Stock price $ 0.01 – 0.04 $ 0.02 – 0.03 Exercise price $ 0.01 – 0.04 $ 0.02 – 0.34 Expected term (in years) 1.00 - 5.00 4.94 – 5.00 Volatility (annual) 195.6% - 297.8 % 196.5% – 380.5 % Risk-free rate 3.48% - 4.25 % 2.42% - 4.22 %

Note 7 - Derivative Liability_

Note 7 - Derivative Liability: Schedule of valuation methodology (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Schedule of valuation methodology	Nine Months Ended March 31, 2024 Stock price $ 0.01 – 0.04 Exercise price $ 0.01 – 0.03 Contractual term (in years) 0.42 – 1.50 Volatility (annual) 237% - 302% Risk-free rate 4.23% – 5.04%

Note 7 - Derivative Liability_2

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Tables)	9 Months Ended
	Mar. 31, 2024
Tables/Schedules
Fair Value, Liabilities Measured on Recurring Basis	Fair value measured at March 31, 2024 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2024 Derivative liability $ - $ - $ 824,775 $ 824,775 Total $ - $ - $ 824,775 $ 824,775 Fair value measured at June 30, 2023 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2023 Derivative liability $ - $ - $ 1,004,846 $ 1,004,846 Total $ - $ - $ 1,004,846 $ 1,004,846
Fair Value, Liabilities Measured on Recurring Basis	Derivative Liability Balance as of June 30, 2023 $ 1,004,846 Additions during the period 288,298 Change due to conversion to stock options (86,199) Reversal of converted options 86,199 Change in fair value (50,843) Change due to termination of conversion feature on debt (417,526) Balance as of March 31, 2024 $ 824,775

Note 1 - Organization and Su_14

Note 1 - Organization and Summary of Significant Accounting Policies: Net Loss per Share (Details) - shares	3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Jun. 30, 2023
Details
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			74,393,933	30,499,099
Restricted stock units excluded in calculation of the weighted-average number of common shares outstanding, unvested	90,000,000	90,000,000

Note 1 - Organization and Su_15

Note 1 - Organization and Summary of Significant Accounting Policies: Inventories (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Details
Inventories	$ 45,373	$ 65,209
Inventory, LIFO Reserve	$ 2,736

Note 2 - Notes payable (Details

Note 2 - Notes payable (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Details
Notes payable	$ 0	$ 16,051

Note 3 - Convertible notes pa_4

Note 3 - Convertible notes payable to stockholder (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Jan. 30, 2024	Sep. 27, 2023	Jun. 30, 2023	Apr. 30, 2023	Apr. 24, 2023	Dec. 21, 2022	Aug. 26, 2022	Feb. 04, 2022
Notes payable to stockholder	$ 380,000			$ 0
August 2022 Note
Debt Instrument, Interest Rate, Stated Percentage								12%
Debt Instrument, Face Amount								$ 325,000
December 2022 Note
Debt Instrument, Interest Rate, Stated Percentage							12%
Debt Instrument, Face Amount							$ 120,000
April 2023
Debt Instrument, Interest Rate, Stated Percentage						12%
Debt Instrument, Face Amount						$ 280,000
April 2023 - Note 2
Debt Instrument, Interest Rate, Stated Percentage					12%
Debt Instrument, Face Amount					$ 100,000
January30, 2024 Note
Debt Instrument, Interest Rate, Stated Percentage		12%
Debt Instrument, Face Amount		$ 30,000
Investor | February 2022 Note
Debt Instrument, Interest Rate, Stated Percentage									12%
Debt Instrument, Face Amount									$ 350,000
Tranches 1 | Principal
Reversal of converted stock options upon amendment of notes payable agreement	100,000
Tranches 1 | Interest
Reversal of converted stock options upon amendment of notes payable agreement	$ 18,016
Tranches 1 | February 2022 Note
Debt Instrument, Face Amount									100,000
Tranches 1 | August 2022 Note
Debt Instrument, Face Amount								125,000
Tranches 1 | December 2022 Note
Debt Instrument, Face Amount							40,000
Tranches 1 | April 2023
Debt Instrument, Face Amount						80,000
Tranches 1 | April 2023 - Note 2
Debt Instrument, Face Amount					20,000
Tranches 2 | February 2022 Note
Debt Instrument, Face Amount									150,000
Tranches 2 | August 2022 Note
Debt Instrument, Face Amount								$ 100,000
Tranches 2 | December 2022 Note
Debt Instrument, Face Amount							20,000
Tranches 2 | April 2023
Debt Instrument, Face Amount						$ 100,000
Tranches 3 | February 2022 Note
Debt Instrument, Face Amount									$ 100,000
First Tranche of February 2022 Note converted to stock options			5,632,283
First Tranche of February 2022 Note converted to stock options, Value			$ 167,961
Tranches 3 | December 2022 Note
Debt Instrument, Face Amount							20,000
Tranches 3 | April 2023 - Note 2
Debt Instrument, Face Amount					$ 40,000
Tranches 4 | December 2022 Note
Debt Instrument, Face Amount							$ 40,000

Note 3 - Convertible notes pa_5

Note 3 - Convertible notes payable to stockholder: Disclosure of Notes payable to stockholders (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Details
Principal balance	$ 1,205,000	$ 895,000
Unamortized debt discount	(344,330)	(480,268)
Notes Payable	$ 860,670	$ 414,732

Note 3 - Convertible notes pa_6

Note 3 - Convertible notes payable to stockholder: Schedule of Debt (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Details
Notes Payable	$ 860,670	$ 414,732
Amortization of debt discount	415,938
Proceeds from Issuance of Long-Term Debt	310,000
Embedded Conversion Feature - debt discount	(280,000)
Notes Payable without conversion feature	(380,000)
Convertible Notes Payable	480,670
Convertible Notes Payable, Current	356,160
Convertible notes payable to stockholder - noncurrent, net	$ 124,510	$ 151,777

Note 5 - Commitments and Cont_2

Note 5 - Commitments and Contingencies (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Details
Purchase of certain intellectual property rights	$ 1,400,000
Payments for Purchase of Other Assets	100,000	$ 0
Common stock to purchase certain intellectual property rights	$ 1,300,000

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Common Stock, Shares, Outstanding	150,543,635		150,543,635		150,543,635
Share-Based Payment Arrangement, Expense	$ 462,059	$ 586,937	$ 1,372,079	$ 1,664,046
Options granted to its board members and consultants			28,710,133
Reversal of conversion			5,638,283
Stock Options
Share-Based Payment Arrangement, Expense	$ 106,560	$ 28,233	$ 297,860	$ 232,324

Note 6 - Stockholders' Defici_4

Note 6 - Stockholders' Deficit: Schedule of Stock Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Share-Based Payment Arrangement, Expense	$ 462,059	$ 586,937	$ 1,372,079	$ 1,664,046
Restricted Stock Awards
Share-Based Payment Arrangement, Expense	355,469	558,714	1,074,219	1,431,722
Stock Options
Share-Based Payment Arrangement, Expense	$ 106,560	$ 28,233	$ 297,860	$ 232,324

Note 6 - Stockholders' Defici_5

Note 6 - Stockholders' Deficit: Schedule of Stock Option Activity (Details)			9 Months Ended
	Mar. 31, 2023 $ / shares shares	Jun. 30, 2022 $ / shares shares	Mar. 31, 2024 $ / shares shares	Mar. 31, 2023 $ / shares shares	Jun. 30, 2023 $ / shares shares
Details
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	30,499,099	23,502,035	74,393,933	30,499,099	51,322,083
Weighted Average Exericse Price, Balance | $ / shares	$ 0.05	$ 0.11	$ 0.04	$ 0.05	$ 0.04
Weighted Average Remaining Life, outstanding	4 years 3 months	2 years 11 months 1 day	3 years 8 months 26 days	4 years 1 month 20 days
Options granted			28,710,133	6,997,064
Weighted Average Exericse Price, Granted | $ / shares			$ 0.03	$ 0.03
Share-based Compensation Arrangement By Share-based Payment Award, Grants In Period, Weighted Average Remaining Contractual Term			6.57	4.69
Reversal of conversion			(5,638,283)
Options exercised			0
Weighted Average Exericse Price, Exercised | $ / shares			$ 0

Note 6 - Stockholders' Defici_6

Note 6 - Stockholders' Deficit: Schedule of Assumptions Used (Details) - $ / shares	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Minimum
Stock Price	$ 0.01
Exercise Price	$ 0.01
Expect term (in years)	5 months 1 day
Volatility (annual)	237%
Risk-free rate	4.23%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.03
Expect term (in years)	1 year 6 months
Volatility (annual)	302%
Risk-free rate	5.04%
Stock Options | Minimum
Stock Price	$ 0.01	$ 0.02
Exercise Price	$ 0.01	$ 0.02
Expect term (in years)	1 year	4 years 11 months 8 days
Volatility (annual)	195.60%	196.50%
Risk-free rate	3.48%	2.42%
Stock Options | Maximum
Stock Price	$ 0.04	$ 0.03
Exercise Price	$ 0.04	$ 0.34
Expect term (in years)	5 years	5 years
Volatility (annual)	297.80%	380.50%
Risk-free rate	4.25%	4.22%

Note 7 - Derivative Liability_3

Note 7 - Derivative Liability: Schedule of valuation methodology (Details)	9 Months Ended
	Mar. 31, 2024 $ / shares
Minimum
Stock Price	$ 0.01
Exercise Price	$ 0.01
Expect term (in years)	5 months 1 day
Volatility (annual)	237%
Risk-free rate	4.23%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.03
Expect term (in years)	1 year 6 months
Volatility (annual)	302%
Risk-free rate	5.04%

Note 7 - Derivative Liability_4

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Fair Value, Inputs, Level 1
Derivative liabilities	$ 0		$ 0		$ 0
Fair Value, Inputs, Level 2
Derivative liabilities	0		0		0
Fair Value, Inputs, Level 3
Derivative liabilities	824,775		824,775		1,004,846
Changes due to issuances			288,298
Change due to conversion to stock options			(86,199)
Reversal of converted options			86,199
Change in fair value of derivative liability			50,843
Change due to extinguishment of underlying debt			(417,526)
Derivative liabilities	824,775		824,775		$ 1,004,846
Change in fair value of derivative liability	$ 79,790	$ 91,241	$ 50,843	$ 341,913

Note 7 - Derivative Liability (

Note 7 - Derivative Liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Details
Change in fair value of derivative liability	$ 79,790	$ 91,241	$ 50,843	$ 341,913
Derivative liabilities	$ 824,775		$ 824,775		$ 1,004,846